Oculis Holding AG SEC filings OCS
Oculis Holding AG has 138 filings in SEC EDGAR's recent list, going back to Nov 7, 2022. Its latest annual report, Form 20-F, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 3, 2026 | — |
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| F-3ASR | Filing | Mar 4, 2026 | — |
| POS AM | Filing | Dec 5, 2025 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 10, 2025 | — |
| 424B5 | Prospectus supplement | Oct 31, 2025 | — |
| 424B5 | Prospectus supplement | Oct 31, 2025 | — |
| S-8 | Employee stock plan registration | Jun 5, 2025 | — |
| 424B5 | Prospectus supplement | Feb 14, 2025 | — |
| 424B3 | Prospectus | Sep 6, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 27, 2024 | — |
| 424B5 | Prospectus supplement | May 8, 2024 | — |
| 424B5 | Prospectus supplement | Apr 11, 2024 | — |
| 424B3 | Prospectus | Apr 3, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 1, 2024 | — |
| POS AM | Filing | Apr 1, 2024 | — |
| 424B3 | Prospectus | Feb 28, 2024 | — |
| 424B3 | Prospectus | Nov 15, 2023 | — |
| 424B3 | Prospectus | Aug 30, 2023 | — |
| 424B3 | Prospectus | Aug 8, 2023 | — |
| 424B3 | Prospectus | Jun 13, 2023 | — |
| 424B3 | Prospectus | Jun 7, 2023 | — |
| 424B4 | Prospectus | Jun 2, 2023 | — |
| F-1 | Registration statement (foreign issuer) | May 30, 2023 | — |
| 424B3 | Prospectus | May 24, 2023 | — |
| S-8 | Employee stock plan registration | May 15, 2023 | — |
| 424B3 | Prospectus | May 1, 2023 | — |
| F-1/A | Filing | Apr 20, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Apr 3, 2023 | — |
| 424B3 | Prospectus | Feb 3, 2023 | — |
| F-4/A | Filing | Feb 1, 2023 | — |
| F-4/A | Filing | Jan 27, 2023 | — |
| F-4/A | Filing | Jan 6, 2023 | — |
| F-4/A | Filing | Dec 12, 2022 | — |
| F-4 | Filing | Nov 7, 2022 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCS (Nasdaq), OCSAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zug, Switzerland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1953530
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.